Table 2.
The detail of baseline after PSM.
| Variable | Total (n = 94) | Group | Statistic | |||
|---|---|---|---|---|---|---|
| Non-Pain (n = 47) | Pain (n = 47) | Z | P | SMD | ||
| Age, M (Q1, Q3) | 62.00 (54.00, 66.00) | 61.00 (53.00, 67.00) | 62.00 (56.00, 66.00) | Z=-0.413 | 0.680 | 0.002 |
| Weight, M (Q1, Q3) | 59.00 (54.00, 65.00) | 58.50 (52.00, 65.75) | 59.50 (56.00, 64.50) | Z=-0.908 | 0.364 | 0.181 |
| Height, M (Q1, Q3) | 168.00 (160.00, 170.00) | 165.00 (159.00, 170.00) | 168.00 (160.50, 170.50) | Z=-0.921 | 0.357 | 0.174 |
| BSA, M (Q1, Q3) | 1.65 (1.57, 1.74) | 1.63 (1.56, 1.76) | 1.66 (1.57, 1.73) | Z=-0.969 | 0.333 | 0.282 |
| Neutrophils, M (Q1, Q3) | 4.66 (3.30, 6.46) | 5.01 (3.72, 6.75) | 4.49 (3.05, 6.37) | Z=-0.866 | 0.387 | -0.084 |
| Lymphocytes, M (Q1, Q3) | 1.44 (1.10, 1.84) | 1.40 (1.11, 1.75) | 1.53 (1.09, 1.93) | Z=-0.609 | 0.543 | 0.209 |
| Leukocytes, M (Q1, Q3) | 7.21 (5.38, 9.32) | 7.25 (5.62, 9.64) | 6.77 (5.04, 8.73) | Z=-0.650 | 0.515 | -0.001 |
| Platelets, M (Q1, Q3) | 272.50 (213.25, 321.75) | 266.00 (213.50, 322.00) | 281.00 (217.00, 321.50) | Z=-0.386 | 0.700 | 0.089 |
| Monocytes, M (Q1, Q3) | 0.54 (0.37, 0.72) | 0.54 (0.36, 0.68) | 0.55 (0.38, 0.83) | Z=-0.495 | 0.620 | 0.114 |
| NLR, M (Q1, Q3) | 3.56 (2.28, 5.43) | 3.89 (2.35, 5.46) | 3.38 (2.25, 5.06) | Z=-0.873 | 0.382 | -0.304 |
| Dnlr, M (Q1, Q3) | 2.12 (1.56, 3.04) | 2.26 (1.65, 3.06) | 1.98 (1.60, 2.82) | Z=-0.945 | 0.345 | -0.335 |
| PLR, M (Q1, Q3) | 189.09 (146.99, 233.83) | 194.44 (151.81, 259.75) | 188.89 (138.38, 227.18) | Z=-1.157 | 0.247 | -0.176 |
| LMR, M (Q1, Q3) | 2.54 (1.74, 3.53) | 2.50 (1.71, 3.38) | 2.54 (1.80, 3.69) | Z=-0.635 | 0.525 | 0.071 |
| SII, M (Q1, Q3) | 870.69 (581.38, 1465.57) | 988.13 (592.40, 1605.02) | 820.99 (571.88, 1411.20) | Z=-0.873 | 0.382 | -0.074 |
| Gender, n (%) | χ²=0.275 | 0.600 | ||||
| 1 | 76 (80.85) | 39 (82.98) | 37 (78.72) | -0.104 | ||
| 2 | 18 (19.15) | 8 (17.02) | 10 (21.28) | 0.104 | ||
| Alcohol, n (%) | χ²=2.014 | 0.156 | ||||
| 0 | 70 (74.47) | 32 (68.09) | 38 (80.85) | 0.324 | ||
| 1 | 24 (25.53) | 15 (31.91) | 9 (19.15) | -0.324 | ||
| ECOG, n (%) | - | 0.180 | ||||
| 0 | 44 (46.81) | 23 (48.94) | 21 (44.68) | -0.086 | ||
| 1 | 43 (45.74) | 18 (38.30) | 25 (53.19) | 0.298 | ||
| 2 | 5 (5.32) | 4 (8.51) | 1 (2.13) | -0.442 | ||
| 3 | 2 (2.13) | 2 (4.26) | 0 (0.00) | -0.298 | ||
| Smoke, n (%) | χ²=0.203 | 0.652 | ||||
| 0 | 28 (29.79) | 13 (27.66) | 15 (31.91) | 0.091 | ||
| 1 | 66 (70.21) | 34 (72.34) | 32 (68.09) | -0.091 | ||
| HBV, n (%) | χ²=0.261 | 0.609 | ||||
| 0 | 90 (95.74) | 44 (93.62) | 46 (97.87) | 0.295 | ||
| 1 | 4 (4.26) | 3 (6.38) | 1 (2.13) | -0.295 | ||
| Tumor, n (%) | χ²=0.103 | 0.748 | ||||
| 1 | 83 (88.3) | 41 (87.23) | 42 (89.36) | 0.069 | ||
| 2 | 11 (11.7) | 6 (12.77) | 5 (10.64) | -0.069 | ||
| Pathology, n (%) | χ²=1.554 | 0.460 | ||||
| 1 | 46 (48.94) | 20 (42.55) | 26 (55.32) | 0.257 | ||
| 2 | 28 (29.79) | 16 (34.04) | 12 (25.53) | -0.195 | ||
| 3 | 20 (21.28) | 11 (23.40) | 9 (19.15) | -0.108 | ||
| T, n (%) | χ²=1.022 | 0.907 | ||||
| 0 | 18 (19.15) | 9 (19.15) | 9 (19.15) | 0.000 | ||
| 1 | 9 (9.57) | 5 (10.64) | 4 (8.51) | -0.076 | ||
| 2 | 15 (15.96) | 6 (12.77) | 9 (19.15) | 0.162 | ||
| 3 | 11 (11.7) | 5 (10.64) | 6 (12.77) | 0.064 | ||
| 4 | 41 (43.62) | 22 (46.81) | 19 (40.43) | -0.130 | ||
| N, n (%) | χ²=0.377 | 0.828 | ||||
| 0 | 14 (14.89) | 6 (12.77) | 8 (17.02) | 0.113 | ||
| 2 | 36 (38.3) | 18 (38.30) | 18 (38.30) | 0.000 | ||
| 3 | 44 (46.81) | 23 (48.94) | 21 (44.68) | -0.086 | ||
| M, n (%) | χ²=0.072 | 0.789 | ||||
| 0 | 17 (18.09) | 8 (17.02) | 9 (19.15) | 0.054 | ||
| 1 | 77 (81.91) | 39 (82.98) | 38 (80.85) | -0.054 | ||
| Lung metastasis, n (%) | χ²=0.720 | 0.396 | ||||
| 0 | 58 (61.7) | 27 (57.45) | 31 (65.96) | 0.180 | ||
| 1 | 36 (38.3) | 20 (42.55) | 16 (34.04) | -0.180 | ||
| Liver metastasis, n (%) | χ²=2.574 | 0.109 | ||||
| 0 | 83 (88.3) | 39 (82.98) | 44 (93.62) | 0.435 | ||
| 1 | 11 (11.7) | 8 (17.02) | 3 (6.38) | -0.435 | ||
| Bone metastasis, n (%) | χ²=0.048 | 0.826 | ||||
| 0 | 63 (67.02) | 32 (68.09) | 31 (65.96) | -0.045 | ||
| 1 | 31 (32.98) | 15 (31.91) | 16 (34.04) | 0.045 | ||
| Brain metastasis, n (%) | χ²=0.066 | 0.797 | ||||
| 0 | 75 (79.79) | 38 (80.85) | 37 (78.72) | -0.052 | ||
| 1 | 19 (20.21) | 9 (19.15) | 10 (21.28) | 0.052 | ||
| Adrenal metastasis, n (%) | χ²=0.072 | 0.789 | ||||
| 0 | 77 (81.91) | 39 (82.98) | 38 (80.85) | -0.054 | ||
| 1 | 17 (18.09) | 8 (17.02) | 9 (19.15) | 0.054 | ||
| Other Lymph node metastasis, n (%) | χ²=0.000 | 1.000 | ||||
| 0 | 76 (80.85) | 38 (80.85) | 38 (80.85) | 0.000 | ||
| 1 | 18 (19.15) | 9 (19.15) | 9 (19.15) | 0.000 | ||
| Pleura metastasis, n (%) | χ²=0.066 | 0.797 | ||||
| 0 | 75 (79.79) | 37 (78.72) | 38 (80.85) | 0.054 | ||
| 1 | 19 (20.21) | 10 (21.28) | 9 (19.15) | -0.054 | ||
| Meningeal metastasis, n (%) | χ²=0.000 | 1.000 | ||||
| 0 | 92 (97.87) | 46 (97.87) | 46 (97.87) | 0.000 | ||
| 1 | 2 (2.13) | 1 (2.13) | 1 (2.13) | 0.000 | ||
Bold values: P value<0.05.